- JONI DEAN
Series Overview
This continuing education series is designed to create a uniform platform that introduces aspects of the changing landscape of pediatric rheumatology practice, incorporating clinical, research, and patient/family perspectives in order to conduct efficient and effective research that will better the lives of children with rheumatic disea+C17se. This series will help new study coordinators understand the field of rheumatology, including specific disease discussion, medications used in rheumatology and labs required for completion of this study. This series will help explain why the Childhood Arthritis and Rheumatology Research Alliance (CARRA) is requiring specific questions to be completed by patient/parent participants.
Target Audience
MD/DO, RN, APRN, Physician Assistants, Pharmacists, and Clinical Trial Coordinators.,
Planning Committee
Dominic Co, Chair | Joni Dean, Coordinator |
Accreditation
Accreditation Statement
![]() | In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) and the Childhood Arthritis and Rheumatology Research Alliance . The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 ANCC contact hour.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity, all relevant financial relationships have been mitigated and detailed disclosures are listed below.
* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Detailed disclosures will be available prior to the start of the activity.
Disclosures for Planning Committee - January 1, 2023 – February 28, 2023
Disclosures for Planning Committee
Competencies
ACGME/NURSING
Medical Knowledge
INTERPROFESSIONAL EDUCATION COLLABORATIVE COMPETENCIES
Interprofessional Communication
Teams and Teamwork
DIVERSITY, EQUITY, AND INCLUSION COMPETENCIES
Address Health Disparities
IP — Competence
As a result of participation in this educational series, participants will increase their ability to:
- Explain why specific labs and medications for treatment of rheumatic diseases are included in research supported by the CARRA Registry
- Identify eligible patients for the CARRA Registry based on the knowledge of specific diseases included in CARRA studies, criteria for diagnosis, and measures used to capture the disease activity or severity
- Approach pediatric patients with rheumatic diseases and families, including those who experience health disparities, to discuss the measures and collect accurate data about the disease and effects of treatment
- Accurately enter data on study patients into the CARRA Registry
- Improve interprofessional communication, and collaborative care and research in the area of pediatric rheumatic diseases